iLead BMS (BioMedicalScience)
New Drug Development Company Specializing in Small Molecule Medicinal Chemistry
General Info.
| Company Name | iLEAD Biomedical Science Inc. |
|---|---|
| CEO | Lee Chae Joon |
| Foundation | December 15, 2020 |
| Address | The First Tower 2 18F 1816 614, Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do, Republic of Korea |
| Main business | New drug development |
Core competencies
Pipelines
(* You can scroll left and right)
| Code | Indication | Discovery | Hit | Lead | NME |
|---|---|---|---|---|---|
| IL2102 | KRAS-driven solid tumors | ||||
| IL2106 | Solid tumors | ||||
| IL2112 | High CXCL12 Fibrotic & Autoimmune diseases | ||||
| IL2112 | MS & ALS | ||||
NME: new molecular entity
